|
Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT1) |
approved
|
604772 |
|
|
|
|
Catecholaminergic Polymorphic Ventricular Tachycardia type 3 (CPVT3) |
approved
|
614021 |
|
|
|
|
Catecholaminergic Polymorphic Ventricular Tachycardia type 4 (CPVT4) |
approved
|
614916 |
|
|
|
|
Catecholaminergic Polymorphic Ventricular Tachycardia type 5 with or without muscle weakness (CPVT5) |
approved
|
615441 |
|
|
|
|
Catecholaminergic Polymorphic Ventricular Tachychardia 2 (CPVT2) |
approved
|
611938 |
|
|
Central Core Disease of Muscle (CCD) |
approved
|
117000 |
|
|
|
|
Centronuclear Myopathy (CNM1) |
approved
|
160150 |
|
|
|
|
Cerebellar Ataxia, Intellectual Disability and Dysequilibrium Syndrome Type 1 |
approved
|
224050 |
|
|
|
|
Cerebellar Ataxia, Intellectual Disability and Dysequilibrium Syndrome Type 2 |
approved
|
610185 |
|
|
|
|
Cerebellar Ataxia, Intellectual Disability and Dysequilibrium Syndrome Type 3 |
approved
|
613227 |
|
|
|
|
Cerebellar Ataxia, Intellectual Disability and Dysequilibrium Syndrome Type 4 |
approved
|
615268 |
|
|
|
|
Cerebral Autosomal Dominant Arteriopathy with Sub cortical infarcts and Leukoencephalopathy (CADASIL) |
approved
|
125310 |
|
|
Cerebral Cavernous Malformations (CCM) |
approved
|
116860 |
|
|
Cerebral Cavernous Malformations 3 (CCM3) |
approved
|
603285 |
|
|
|
|
Cerebral Creatine Deficiency Syndrome 1 (CCDS1) |
approved
|
300352 |
|
|
|
|
Cerebral Creatine Deficiency Syndrome 2 (CCDS2) |
approved
|
612736 |
|
|
|
|
Cerebral Creatine Deficiency Syndrome 3 (CCDS3) |
approved
|
612718 |
|
|
|
|
Cerebro-oculo-facial-skeletal syndrome Type 1 (COFS1) |
approved
|
214150 |
|
|
|
|
Cerebro-oculo-facial-skeletal syndrome Type 2 (COFS2) |
approved
|
610756 |
|
|
|
|
Cerebro-oculo-facial-skeletal syndrome Type 3 (COFS3) |
approved
|
616570 |
|
|
|
